A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
about
My approach to the treatment of sclerodermaManagement of Systemic-Sclerosis-Associated Interstitial Lung DiseasePrevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisRole of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung diseaseRace and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature.Clinical and autoimmune profile of scleroderma patients from Western India.Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts.Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.Pulmonary involvement in systemic sclerosis: A clinical profile.Clinical and serological features of systemic sclerosis in a Chinese cohort.Racial differences between blacks and whites with systemic sclerosisInterleukin-33 potentiates bleomycin-induced lung injury.Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.Update on systemic sclerosis.The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.Interstitial lung disease in South Africans with systemic sclerosis.Disease-related autoantibody profile in patients with systemic sclerosis.Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.African-American Race and Mortality in Interstitial Lung Disease: A Multicenter Propensity-Matched Analysis.
P2860
Q24618843-202F231D-A39D-44B1-A87B-A8F3F80C1F74Q26799573-3E4F2FE1-41C4-46A6-96EA-4921B6E76AA0Q27000819-B2203DAB-40EE-4B30-B1A6-646C3E1F59BFQ33737250-6C63C2E6-0F77-4EA9-BD4D-C9A1BCE9DF34Q33929738-D2436370-3A73-4482-8CF7-07219AFBD068Q33956830-7624A2F9-03C9-4455-A833-66DB7770A813Q34154288-9C02D6BF-B14D-4F73-B41E-9322F7C708BBQ34352783-0564A353-43E6-487B-AC21-42A8AA32F944Q34438113-BF783272-29AD-4A7D-AABA-28D9ABF1036DQ36001984-349AAE63-BD4E-47A8-B367-7CF5FE2CA94FQ36120072-921694D7-672A-4FD9-8F6D-F0FC00101918Q36685226-B5D055DE-A444-470B-9C65-F6A301A3F5DAQ36701466-3DE5BB84-FDD8-4E3B-9E9F-F1A7ADA22A97Q37073717-E8B098E8-918E-40C0-9E2F-072917BDA039Q37129649-59595878-AB91-458A-9CAA-A545C26F6A3BQ37596499-EB24C87E-F73B-4C8F-B337-DDF164E2BCE1Q38156227-0B3FA170-FD6B-46AF-AAE9-D4F1703DCAECQ38187607-55079EAA-C6C1-4642-BE2F-6E84A560C380Q38542317-C463EF2B-9294-461F-A5A2-05FC184C4659Q38730172-CD8D6992-F687-4B84-9D56-F3C4DC470953Q38862644-A2983628-F2D9-46E5-9A9C-B6F304980C09Q39437352-764D045D-C2C5-46DF-B4CD-13E5DFC37777Q40656308-F46387E7-5C9B-4AD0-A823-4F07A5E29338Q46176565-E4C99CAA-7483-4A50-95D5-701EE70B4F1DQ47685250-7B78007E-F69B-4627-AC4C-BBED9CF54B8CQ49486890-FBBB7306-2171-45A1-9D3B-AD7C705C7BE4Q53686363-7C39D65B-EAFB-44A6-8770-6770D586586D
P2860
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A clinical and serologic compa ...... ients with systemic sclerosis.
@ast
A clinical and serologic compa ...... ients with systemic sclerosis.
@en
type
label
A clinical and serologic compa ...... ients with systemic sclerosis.
@ast
A clinical and serologic compa ...... ients with systemic sclerosis.
@en
prefLabel
A clinical and serologic compa ...... ients with systemic sclerosis.
@ast
A clinical and serologic compa ...... ients with systemic sclerosis.
@en
P2093
P2860
P356
P1476
A clinical and serologic compa ...... ients with systemic sclerosis.
@en
P2093
Mary Lucas
Noreen Fertig
Robyn T Domsic
Thomas A Medsger
Virginia Steen
P2860
P304
P356
10.1002/ART.34482
P577
2012-09-01T00:00:00Z